CXCR4 is downregulated in dormant breast cancer cells in the lungs, and the upregulation of CXCR4 with its ligand, CXCL12, promotes AKT signaling and proliferation (Zhao et al., 2008; Nobutani et al., 2015). The gene discussed is CXCL12; the disease is breast carcinoma.